… that afatinib had greater efficacy than gefitinib or erlotinib in … However, afatinib was more
effective than erlotinib as second-… rate of afatinib was comparable to that of erlotinib but higher …

… For the purpose of presenting an illustrative example, we used the results of LUX-Lung 7
to estimate the additional clinical benefit of afatinib versus gefitinib 5 and the results of the …

… use before registration who had ever received afatinib treatment for non–small cell lung …
received gefitinib or erlotinib hydrochloride treatment before commencing afatinib therapy, …

… However, whether gefitinib, erlotinib, or afatinib is most … the effectiveness of gefitinib, erlotinib,
and afatinib. We retrospectively … failure (gefitinib: 9.2 months; erlotinib: 9.8 months; afatinib: …

… We surveyed the effectiveness of afatinib and gefitinib/erlotinib … However, Chiu et al.
reported gefitinib and erlotinib were … the efficacy of gefitinib/erlotinib and afatinib in patients with …

… of clinical use of three EGFR TKIs (afatinib, gefitinib, and erlotinib). We found that gefitinib
was more commonly used than erlotinib or afatinib in Korea, especially for elderly, which may …

… The current study indicated that erlotinib, gefitinib, afatinib and icotinib … Erlotinib and afatinib
revealed potentially better efficacy but significant higher toxicities compared with gefitinib …

… studies comparing gefitinib, erlotinib, and afatinib. … While gefitinib, erlotinib, and afatinib have
proven efficacy in patients with … the efficacy of erlotinib, gefitinib, and afatinib in patients with …

… The result of this study provides evidence that gefitinib, erlotinib, and afatinib have similar
effectiveness in advance stage EGFR mutation lung adenocarcinoma patients. Afatinib tends …

… was 0.63 (95% CI, 0.47–0.83) compared with gefitinib or erlotinib. In the competing risk … ,
afatinib showed a lower cumulative incidence of CNS failure compared with gefitinib or erlotinib …